Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2025-12-25 @ 3:29 AM
NCT ID:
NCT01407705
Eligibility Criteria:
Inclusion Criteria:
* For inclusion to the Cervical Spinal Cord (CSM)
* Clinical and Radiographic evidence of cervical spondylotic myelopathy
* 18 to 80 years of age
* Safe and stable clinical scenario to undergo imaging
* Awake, alert patient able to cooperate with physical examination
* Give written informed consent prior to any testing under this protocol
For inclusion to the Control Group, subject must have:
* No diagnosis of cervical degenerative or traumatic disease
* 30 to 80 years of age
* Ability of volunteers to tolerate 1 hr examination
For inclusion to the Degenerative Disease Group, subject must:
* Have signs or symptoms consistent with spinal cord injury.
* Be diagnosed with cervical spondylosis (degenerative disease).
For inclusion to the Traumatic Group, subject must have:
• A spinal cord injury associated with a traumatic event.
Exclusion Criteria:
* For exclusion to the Cervical Spinal Cord (CSM):
* Unsafe or unstable clinical scenario
* Prior cervical spine surgery
* History of neurological disease (stroke, multiple sclerosis, peripheral neuropathy, or other neurodegenerative conditions)
* Inability to comply with physical examination
* Contraindications to MRI imaging (metal debris, cardiac pacemaker, etc..)
* Pregnant women
For exclusion to the other groups:
* Inability to comply with physical examination
* Contraindications to MRI imaging (metal debris, cardiac pacemaker, etc..)
* Pregnant women
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01407705
Study Brief:
Protocol Section:
NCT01407705